ZNF599
Zinc finger protein 599
Also known as: FLJ30663, ZN599_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96NL3
- Gene
- ZNF599
- Ensembl
- ENSG00000153896
- Chromosome
- 19
- Canonical length
- 588 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Plasma membrane,Cytosol
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
588 residues, UniProt reviewed canonical sequence.
>Q96NL3|ZNF599
1 MAAPALALVS FEDVVVTFTG EEWGHLDLAQ RTLYQEVMLE TCRLLVSLGH PVPKPELIYL
61 LEHGQELWTV KRGLSQSTCA GEKAKPKITE PTASQLAFSE ESSFQELLAQ RSSRDSRLGQ
121 ARDEEKLIKI QEGNLRPGTN PHKEICPEKL SYKHDDLEPD DSLGLRVLQE RVTPQDALHE
181 CDSQGPGKDP MTDARNNPYT CTECGKGFSK KWALVRHQQI HAGVKPYECN ECGKACRYMA
241 DVIRHMRLHT GEKPYKCIEC GKAFKRRFHL TEHQRIHTGD KPYECKECGK AFTHRSSFIQ
301 HNMTHTREKP FLCKECGKAF YYSSSFAQHM RIHTGKKLYE CGECGKAFTH RSTFIQHNVT
361 HTGEKPFLCK ECGKTFCLNS SFTQHMRIHT GEKPYECGEC GKAFTHRSTF IRHKRTHTGE
421 KPFECKECGK AFCDSSSLIQ HMRIHTGEKP YECSECGKAF THHSVFIRHN RTHSGQKPLE
481 CKECAKAFYY SSSFTRHMRI HTGEKPYVCR ECGKAFTQPA NFVRHNRIHT GEKPFECKEC
541 EKAFCDNFAL TQHMRTHTGE KPFECNECGK TFSHSSSFTH HRKIHTRVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF599 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- testis: 13 nTPM
- epididymis: 11 nTPM
- choroid plexus: 11 nTPM
- pituitary gland: 10 nTPM
- thyroid gland: 10 nTPM
- kidney: 10 nTPM
Single-cell type
- early spermatids: 84 nCPM
- late primary spermatocytes: 60 nCPM
- late spermatids: 45 nCPM
- epididymal efferent duct ciliated cells: 34 nCPM
- epididymal principal cells: 34 nCPM
- fallopian tube ciliated cells: 33 nCPM
Immune cell
- eosinophil: 3.5 nTPM
- memory CD4 T-cell: 3.5 nTPM
- naive CD4 T-cell: 3.5 nTPM
- NK-cell: 3.5 nTPM
- gdT-cell: 3.4 nTPM
- naive CD8 T-cell: 3.2 nTPM
Brain region
- choroid plexus: 12 nTPM
- white matter: 9.7 nTPM
- midbrain: 8.9 nTPM
- basal ganglia: 8.8 nTPM
- cerebellum: 8.6 nTPM
- hypothalamus: 8.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.97
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.13
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF599 as an antibody target. Whether an autoantibody or antibody against ZNF599 could matter depends on whether native ZNF599 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF599 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF599 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...